Balyasny Asset Management’s SkinHealth Systems SKIN Stock Holding History

Balyasny Asset Management’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.8K	Buy	+22,794	New	+$17.4K	﹤0.01%	2930
2023 Q3	–	Sell	-201,100	Closed	-$1.68M	–	2684
2023 Q2	$1.68M	Sell	201,100 -23,000	-10%	-$239K	﹤0.01%	1432
2023 Q1	$2.83M	Buy	+224,100	New	+$2.59M	0.01%	1324
2022 Q4	–	Sell	-231,300	Closed	-$2.5M	–	3196
2022 Q3	$2.73M	Buy	231,300 +107,000	+86%	+$1.35M	0.01%	1336
2022 Q2	$1.6M	Buy	+124,300	New	+$1.67M	0.01%	1526
2021 Q4	–	Sell	-431,728	Closed	-$11.2M	–	2561
2021 Q3	$11.2M	Buy	+431,728	New	+$9.49M	0.05%	525

Other funds holding SKIN

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

SPC

Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Balyasny Asset Management's SKIN Position: Q2 2026 in Review

Balyasny Asset Management opened a new position in SkinHealth Systems (SKIN) in Q2 2026: 22,794 shares worth $15.8K. The stake represents ﹤0.01% of the portfolio and ranks #2930 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in SKIN as recently as Q2 2023.

Balyasny Asset Management first reported a position in SKIN in Q3 2021 and has held it in 6 quarters since. The position peaked at $11.2M in Q3 2021. 97 funds tracked by Wall St. Rank hold SKIN as of Q2 2026.

Balyasny Asset Management held 22,794 shares of SkinHealth Systems worth $15.8K as of Q2 2026.
SkinHealth Systems was a new Balyasny Asset Management position in Q2 2026.
SkinHealth Systems made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2930 holding.
Balyasny Asset Management first reported a position in SkinHealth Systems in Q3 2021 and has held it in 6 quarters since.
Balyasny Asset Management's SkinHealth Systems position peaked at $11.2M in Q3 2021.
97 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.